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Abstract: The high global demand of wheat and its subsequent consumption arise from the
physicochemical properties of bread dough and its contribution to the protein intake in the human diet.
Gluten is the main structural complex of wheat proteins and subjects affected by celiac disease (CD)
cannot tolerate gluten protein. Within gluten proteins, α-gliadins constitute the most immunogenic
fraction since they contain the main T-cell stimulating epitopes (DQ2.5-glia-α1, DQ2.5-glia-α2,
and DQ2.5-glia-α3). In this work, the celiac immunotoxic potential of α-gliadins was studied within
Triticeae: diploid, tetraploid, and hexaploid species. The abundance and immunostimulatory capacity
of CD canonical epitopes and variants (with one or two mismatches) in all α-gliadin sequences were
determined. The results showed that the canonical epitopes DQ2.5-glia-α1 and DQ2.5-glia-α3 were
more frequent than DQ2.5-glia-α2. A higher abundance of canonical DQ2.5-glia-α1 epitope was
found to be associated with genomes of the BBAADD, AA, and DD types; however, the abundance
of DQ2.5-glia-α3 epitope variants was very high in BBAADD and BBAA wheat despite their low
abundance in the canonical epitope. The most abundant substitution was that of proline to serine,
which was disposed mainly on the three canonical DQ2.5 domains on position 8. Interestingly,
our results demonstrated that the natural introduction of Q to H at any position eliminates the
toxicity of the three T-cell epitopes in the α-gliadins. The results provided a rational approach for
the introduction of natural amino acid substitutions to eliminate the toxicity of three T-cell epitopes,
while maintaining the technological properties of commercial wheats.
Keywords: celiac disease; α-gliadin; 33-mer; DQ2.5-glia-α1; DQ2.5-glia-α2; DQ2.5-glia-α3 epitopes;
wheat species
1. Introduction
Wheat is one of the most widely cultivated cereals in the world and constitutes a major source
of energy, protein, and fiber in the diet. Increasing global demand for wheat and its subsequent
consumption, with an annual production of about 750 million tons, is due to its unique viscoelastic
properties for its inclusion in food products and to industrialization and westernization [1–3].
The wheat group has evolved through allopolyploidization, that is, through hybridization between
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species from the genera Aegilops and Triticum followed by genome doubling [4]. Genetic studies
have provided valuable information regarding which wild cereal species are the relatives of modern
domesticated cereals, and which geographical wild plant produced the domesticated forms that are
used in food production today [5]. The diploid wild wheat that was first domesticated is thought to
have been Triticum monococcum (AmAm), which is still growing in some parts of the world both for
animal feed and human consumption. Wheats with more than one genome are known as polyploid
wheats. The AA genome of the tetraploid wheats is closely similar to that of T. urartu, and the BB
genome is related to Aegilops speltoides (BB). The wild tetraploid, formed after the hybridization,
was designated as Triticum turgidum ssp. dicoccoides (wild emmer; BBAA), and the first domesticated
tetraploid was T. turgidum ssp. dicoccum (cultivated emmer; BBAA), from which, the cultivated
T. turgidum ssp. durum has evolved. The hexaploid wheat, Triticum aestivum ssp. aestivum (BBAADD),
consists of three genomes designated A, B, and D. The A and B genomes of hexaploid wheats come
from the A and B genomes of tetraploid wheat. The hexaploid wheats resulted from the hybridization
of cultivated emmer and a wild grass species identified as Aegilops tauschii (DD), followed by polyploid
formation which gave rise to a new species that has three genomes designated BBAADD [6,7]. The main
wheat species grown throughout the world is the hexaploid T. aestivum, usually called “common” or
“bread” wheat. In terms of total production, the next variety in importance is the tetraploid durum
or macaroni wheat (T. turgidum L. subsp. durum Desf.). This is adapted to hot dry climates and is
widely used for the production of pasta. Common wheat species account for nearly 94% of the total
production, with durum wheat representing 5%, and other wheat forms about 1% [6,8].
Although wheat has always been recognized as a fundamental food, this cereal cannot be tolerated
by certain individuals since it is responsible for significant pathologies, called gluten-related disorders,
such as celiac disease (CD), wheat allergy, non-celiac gluten sensitivity, gluten ataxia, and dermatitis
herpetiformis [9]. CD is an immune-mediated systemic disorder elicited by the ingestion of gluten
in genetically susceptible individuals. It affects around 1% of the global population and is based
on a variable combination of intestinal and extra-intestinal signs and symptoms, celiac specific
antibodies, HLA-DQ2/8 haplotypes, and enteropathy [9–11]. Gluten proteins are rich in proline
and glutamine residues, which make them resistant to being fully digested in the gastrointestinal
track. Partial digestion of gluten generates small peptides that provoke autoimmune disorders in celiac
people. The most accepted model for explaining CD immunopathogenesis is the two-signal model [12]
characterized by a first innate immune response followed by a secondary antigen-specific adaptive
response. According to this model, certain peptides, such as the 19-mer gliadin peptide, trigger an
innate immune response [13] mainly characterized by the production of interleukin 15 (IL-15) by
epithelial cells. The result is the disruption of the epithelial barrier by increasing the permeability
and inducing enterocyte apoptosis [14]. As a consequence, the immune-adaptive peptides, like the
33-mer, can now reach the lamina propria where they are deaminated by the tissue transglutaminase
(tTG2). Such deamidation provides a negative charge to gliadin peptides and hence enhances their
affinity to bind within the HLA-DQ2/8 bound, which is also the ‘susceptibility gene’ in CD, expressed
on the surface of dendritic cells (DCs) [15–17]. DCs are therefore central in CD pathogenesis since
they present a gluten antigen to T cells, [18] thereby driving progression of the pro-inflammatory
antigen-specific adaptive immune response, which will turn into the symptomatology of the disease.
Gluten is a complex mixture of storage proteins of cereals such as wheat, rye, barley, oats,
and their hybrid derivatives. Gluten proteins have been classified according to their solubility [19].
In wheat, these proteins are defined as gliadins (soluble in 60–70% ethanol) and glutenins (only soluble
under stronger conditions, i.e. acids, reducing agents and detergents, urea, etc.) [20]. According to
their electrophoretic mobilities, gliadins are divided into three groups: α- and β-gliadins, γ-gliadins,
andω-gliadins [19], while the glutenins are divided into the high molecular weight (HMW) and the
low molecular weight (LMW) glutenin subunits (GSs) [21,22]. Among the gliadins, the α-gliadins
have the strongest immunogenicity [23], and four T-cell stimulatory epitopes have been identified as
being responsible for eliciting the immunogenicity of α-gliadin. Two of these are the major epitopes
Nutrients 2019, 11, 220 3 of 13
and they are present in the 33-mer peptide, which is the main contributor to the immunogenicity
of the gluten [24] and contains six copies of these two overlapping T-cell epitopes: three copies of
the DQ2.5-glia-α1 and three copies of the DQ2.5-glia-α2. The other two T-cell stimulatory epitopes
are minor epitopes: DQ2.5-glia-α3 and DQ8-glia-α1 [24–27]. However, natural substitutions of these
canonical epitopes could also contribute to the toxicity of wheat [28], and it could suggest that the
total CD immunogenicity of gluten protein is a result of the canonical epitopes and their variants,
some of which are more abundant than the canonical epitopes themselves. Gluten can have different
immunogenic potential sequences whose proportions in each species are also variable. For this reason,
it is important to study the amino acid substitutions in the variants of these epitopes; interestingly,
these variants could increase, reduce, or suppress the CD response.
In earlier work, next-generation sequencing and Sanger sequencing of α-gliadins from diploid
and polyploid wheats provided six types of α-gliadins with major differences in their frequencies.
The canonical CD epitopes and their variants were identified in the different types of α-gliadins [29].
In the present study, we used the sequence data with one or two mismatches and canonical epitopes
obtained in Ozuna et al. [29], and we have built upon the previous research by exploring the abundance
of different DQ2.5-glia-α1, DQ2.5-glia-α2, and DQ2.5-glia-α3 epitope variants per species in diploid
and polyploid wheats. Moreover, the immunogenic potential of these epitope variants in wheat species
was studied by testing their binding capacity to anti-33-mer monoclonal antibodies (moAbs) [30,31]
and to induce T-cell proliferation. The anti-33-mer antibodies were able to detect the presence of gliadin
33-mer related epitopes in prolamins from wheat, barley, rye, and various oats varieties as well as in
food samples and human samples to monitor gluten free diet (GFD) compliance and transgressions [32].
Our study showed that the canonical epitopes DQ2.5-glia-α1 and DQ2.5-glia-α3 were more frequent
than DQ2.5-glia-α2. The most abundant natural modification was found in the DQ2.5-glia-α3 domain
in all the sequences studied. However, this variant decreased its immunogenicity with respect to
the canonical epitope. On the other hand, one of the most representative variants of DQ2.5-glia-α2
(40%) showed an immunogenicity equivalent to the canonical epitope. Our results provide a rational
approach for the introduction or selection of natural amino acid substitutions to eliminate the toxicity
of three α-gliadin T-cell epitopes, while keeping the technological properties of the commercial wheats.
2. Materials and Methods
2.1. Catalogue and Abundance of CD Epitopes from Diploid, Tetraploid, and Hexaploid Wheat Varieties
Canonical epitopes DQ2.5-glia-α1 (PF/YPQPQLPY), DQ2.5-glia-α2 (PQPQLPYPQ), and
DQ2.5-glia-α3 (FRPQQPYPQ) and variants with one or two mismatches provided by Ozuna et al. [29]
were obtained from diploid, tetraploid, and hexaploid wheats (Figure 1).
The frequency/abundance of each peptide in the sequences of the different wheats was studied
in silico. The abundance of each epitope was calculated by multiplying the total number of epitopes
found in a given gene by the frequency of that gene in the genome.
These canonical CD epitopes and their most representative variants with one or two mismatches
were synthesized as deaminated and non-deaminated 9-mer peptides. The peptides were supplied by
Biomedal S.L. (Seville, Spain).
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Figure 1. Schematic representation of 96 accessions from Triticum and Aegilops sp. showing their 
origin and breeding status. In total, there are thirty-five accessions of hexaploid wheats, thirty-seven 
accessions of tetraploid wheats, and twenty-four accessions of diploid wheats. AA, BB, and DD: 
diploids; BBAA: tetraploids; BBAADD: hexaploids (partially adapted from Ozuna and Barro) [3]. 
The frequency/abundance of each peptide in the sequences of the different wheats was studied 
in silico. The abundance of each epitope was calculated by multiplying the total number of epitopes 
found in a given gene by the frequency of that gene in the genome. 
These canonical CD epitopes and their most representative variants with one or two mismatches 
were synthesized as deaminated and non-deaminated 9-mer peptides. The peptides were supplied 
by Biomedal S.L. (Seville, Spain). 
2.2. Enzyme-Linked Immunosorbent Assay (ELISA) 
Maxisorp microtitre plates (Nunc, Roskilde, Denmark) were coated with gliadin solution 
(Sigma, St Louis, MO, USA) and incubated overnight at 4 °C. The plates were washed with 
phosphate-buffered saline (PBS) containing 0.05% Tween 20 and blocked with PBS-bovine serum 
albumin (BSA) 3% for 1 h at room temperature (RT), and 33-mer peptide was used as standard. Serial 
dilutions of peptides were made, to each of which horseradish peroxidase (HRP)-conjugate with anti-
33-mer antibody (moAb) was added [32]. The samples were pre-incubated at RT for 1 h and then 
added to the wells. After 1 h of incubation at RT, the plates were washed and substrate solution (TMB, 
Sigma) was added. The reaction was stopped at 15 min with 1 M sulfuric acid and the absorbance at 
450 nm was measured (microplate reader UVM340; Asys Hitech GmbH, Eugendorf, Austria). Two 
separate assays were performed, each with two repetitions. 
2.3. Peripheral Blood Mononuclear Cells (PBMCs) and Cell Cultures 
Peripheral blood mononuclear cells from 18 child patients with active CD on a gluten-containing 
diet were isolated from 6 mL of heparinized blood by Histopaque gradient centrifugation and 
cultured at a density of 1×106 cells per milliliter in 96-multiwell culture plates in RPMI-1640 culture 
medium (Sigma-Aldrich) supplemented with 10% fetal bovine serum (GIBCO-Invitrogen Ltd), 1% 
penicillin-streptomycin, and 0.1% gentamicin (Sigma-Aldrich). After 48 h, PBMCs were incubated 
with different peptides (50 µg/mL). After 48 h of stimulation, the free supernatants were collected 
and stored at −80 °C until the interferon gamma (IFN-γ) analyses were carried out.  
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2.2. Enzyme-Linked Immunosorbent Assay (ELISA)
Maxisorp microtitre plates (Nunc, Roskilde, Denmark) were coated with gliadin solution (Sigma,
St Louis, MO, USA) and incubated overnight 4 ◦C. The plates were washed with phosphate-buffered
saline (PBS) containing 0.05% Tween 20 and blocked with PBS-bovi e serum albumin (BSA) 3% for
1 h at room temperature (RT), and 33-mer peptide was used as stan ard. S rial dilutions of peptides
were a e, to each of which horseradish peroxidase (HRP)-conjugate with anti-33-mer antibody
(moAb) was added [32]. The samples were pre-incubated at RT for 1 h and then added to the wells.
After 1 h of incubation at RT, the plates were washed and substrate solution (TMB, Sigma) was added.
The reaction was stopped at 15 min with 1 M sulfuric acid and the absorbance at 450 nm was measured
(microplate reader UVM340; Asys Hitech GmbH, Eugendorf, Austria). Two separate assays were
performed, each with two repetitions.
2.3. Peripheral Blood Mononuclear Cells (PBMCs) and Cell Cultures
Peripheral blood mononuclear cells from 18 child patients with active CD on a gluten-co taining
diet were isolated from 6 mL of heparinized blood by Histopaque gradient centrifugation and
cultured t a ensity of 1 × 106 cells per milliliter in 96-multiwell c lt e plates in RPMI-1640 culture
medium (Sig a-Aldrich) sup lemented with 10% fetal bovine serum (GIBCO-Invitrogen Ltd), 1%
penicillin-streptomycin, and 0.1% gentamicin (Sigma-Aldrich). After 48 h, PBMCs were incubated
with different peptides (50 µg/mL). After 48 h of stimulation, the free supernatants were collected and
stored at −80 ◦C until the int rferon gamma (IFN-γ) analyses were carried out.
2.4. Cell Proliferation Analysis
T-cell proliferation was determined after 48 h of incubation using the ELISA
5-bromo-2-deoxyuridine (BrdU) cell proliferation test (Millipore Chemicon, Temecula, California, USA).
The stimulation index (SI) value was calculated by dividing the mean absorbance at 450 nm after
stimulation by the mean absorbance of T cells exposed to the culture medium alone (negative control).
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2.5. IFN-γ Production
Supernatants from the PBMC culture were collected after 48 h and stored at 80 ◦C for IFN- γ
determination using a commercial ELISA kit in accordance with the manufacturer’s instructions
(Thermo Scientific, Madrid, Spain). Standards were run on each plate. The sensitivity of the assay was
<2 pg/mL.
2.6. Statistical Analysis of T Cells and IFN-γ Assays
Each experiment was carried out in duplicate on separate days. The data is expressed as mean
and SD. All statistical analyses were performed with the STATGRAPHICS Centurion XVI program.
The analysis of variance (ANOVA), followed by the Tukey test for mean multiple comparison, was used.
In this study, p values lower than 0.05 (p < 0.05) were considered significant.
3. Results and Discussion
3.1. Relative Abundance of DQ2.5-Glia-α1, DQ2.5-Glia-α2, and DQ2.5-Glia-α3 Domains and Their Variants
in Triticum and Aegilops Species
The complete repertoire of peptides involved in the pathogenesis of CD remains a daunting
task due to the great heterogeneity of gluten proteins [23,26]. Several studies have demonstrated
that peptides derived from α-gliadins induce the strongest T-cell responses in the vast majority of
patients [23,33–35]. The α-gliadins can have different sequences and their proportions in each species
are also variable. In the present study, we have explored the abundance of different DQ2.5-glia-α1,
DQ2.5-glia-α2, and DQ2.5-glia-α3 variants in 96 genotypes from diploid and polyploid wheats. Among
these genotypes, 27 accessions were commercial lines and 69 were non-commercial lines (Figure 1).
The DQ2.5-glia-α epitopes are located in the 33-mer region of α-gliadins (Figure 2a). Although
seventy-eight variants were found for these three canonical epitopes across the Triticeae species [29],
only the most representative variants (covered by >80 reads), encompassing one or two mismatches,
were used for this study; of which 9 variants were from DQ2.5-glia-α1, 10 from DQ2.5-glia-α2, and 14
from DQ2.5-glia-α3 (Figure 2b).
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Figure 2. Celiac disease (CD) epitopes and variants derived from α-gliadin. (a) Location of canonical 
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Figure 2. Celiac disease (CD) epitopes and variants derived fro α-gliadin. (a) Location of canonical
epitopes DQ-2.5-glia-α1, DQ-2.5-glia-α2, and DQ-2.5-glia-α3 into α-gliadin protein. (b) Variants of the
canonical CD epitopes with one or two mismatches selected with more than 80 reads found in Triticum
and Aegilops ssp. The mismatches are indicated in red.
In view of the total abundance of the different canonical epitopes, DQ2.5-glia-α1 and
DQ2.5-glia-α3 were more abundant than DQ2.5-glia-α2 (p < 0.05, Figure 3). There were no significant
differences between the abundance of DQ2.5-glia-α1 and DQ2.5-glia-α3, however, we found higher
variability of the DQ2.5-glia-α1 canonical epitope in hexaploid wheats, since its abundance fluctuated
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widely depending on the different hexaploid species, while it remained evenly distributed in the
DQ2.5-glia-α3 canonical epitope (p = 0.02, Figure 3).
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Figure 3. Abundance of CD canonical epitope and variants per wheat genome type. (a) Abundance
of the canonical epitope DQ2.5-glia-α1 and variants, (b) abundance of the canonical DQ2.5-glia-α2
epitope and variants, and (c) abundance of the canonical DQ2.5-glia-α3 epitope and variants. BBAADD:
hexaploid genome; BBAA: tetraploid genome; AA, DD, and BB: diploid genomes.
Figure 4 shows the abundance of CD canonical epitopes and variants per species. The percentage
of DQ2.5-glia-α1 canonical epitope with respect to variants was 80%. This epitope was present
in all wh at g nomes with the exception of BB diploids. The high st abundance was found in
T. compactum, T. monococcum, nd Ae. tauschii. The most abundant va iant (range from 0.1% to 20%) was
P1Y2P3Q4P5 6 7 8P9 with two mismatches (P to F at p8 and Y to P at p9). This v riant was prese t in
all wheat genomes with the xception of B and D diploids. The next most abundant variant was the
substit tion of P t L at p5, but this variant was present in only BBAA and BB genomes (Figure 5).
The percentage of DQ2.5-glia-α2 canonical epitope with respect to the different variants of
this epitope was 14%, and this epitope was only present in hexaploids BBAADD and DD diploids.
This finding may indicate that this epitope came from Ae. tauschii, the donor of the D genome to
bread wheat. The DQ2.5-glia-α2 variants P1Q2P3Q4L5P6Y7S8Q9 and P1Q2P3Q4P5Q6Y7P8Q9 were the
most frequent (80%). The highest abundance score (range from 46% to 74%) of P1Q2P3Q4L5P6Y7S8Q9
(P to S substitution at p8) occurred in AA diploids and was absent from DD and BB diploid genomes.
In contrast, P1Q2P3Q4P5Q6Y7P8Q9 (L to P at p5 and P to Q at p6), with two mismatches, presented
high abundance in all genomes, with the exception of T. monococcum (AmAm diploid) (Figures 4 and 5).
Regarding the DQ2.5-glia-α3, the epitope variant F1P2P3Q4Q5P6Y7P8Q9 (with R to P substitution
at p2) was the most frequent, with an abundance greater than 75% across all species, except in Triticum
polonicum (BBAA) and Triticum urartu (AuAu), with abundances of 67.9% and 42.2%, respectively.
The second and third most frequent variants, F1L2P3Q4L5P6Y7P8Q9 (R to L at p2 and Q to L at p5) and
F1P2P3Q4Q5S6Y7P8 9 (R to P at p2 and P to S at p6), had two mismatches and were absent in AA
and DD diploid gen mes, which could indicate that the BB genome is the origin of this variant i the
polyploid varieties; in fact, the bundance of this epitope variant in the remaining ge omes was very
similar (≈20%) (Figures 4 and 5).
The process of hybridization between Ae. tauschii and T. dicoccum provided the DD genome,
and new gluten gene combinations, to hexaploid wheats, thereby considerably improving their bread
baking properties compared to that of tetraploid wheats, particularly the HMW-glutenin subunits [36].
However, the DD genome also encodes for gliadins that have been reported as highly immunogenic,
as the DD genome has the highest number of potential immunogenic α-gliadin peptides [37], while
those from the BB genome contribute the least [38,39]. We found that the three canonical epitopes are
present in the DD genome, with a representation ranging from 43% to 65%. In hexaploids (BBAADD),
all canonical epitopes are also present, but in a smaller proportion (<40%) than the DD genome.
In contrast, in the AA genome, only DQ2.5-glia-α1 and DQ2.5-glia-α3 are present, and the BB genome
is not represented by any of the canonical epitopes.
Nutrients 2019, 11, 220 7 of 13
Nutrients 2018, 10, x FOR PEER REVIEW  7 of 14 
 
 
Figure 4. Abundance of CD canonical epitopes and variants per wheat species. (a) Abundance in the 
DQ2.5-glia-α1 epitope variants, (b) abundance in DQ2.5-glia-α1 epitope variants by species, (c) 
abundance in DQ2.5-glia-α2 epitope variants, (d) abundance in DQ2.5-glia-α2 epitope variants by 
species, (e) abundance in DQ2.5-glia-α3 epitope variants, and (f) abundance in DQ2.5-glia-α2 epitope 
variants by species. 
The process of hybridization between Ae. tauschii and T. dicoccum provided the DD genome, and 
new gluten gene combinations, to hexaploid wheats, thereby considerably improving their bread 
baking properties compared to that of tetraploid wheats, particularly the HMW-glutenin subunits 
[36]. However, the DD genome also encodes for gliadins that have been reported as highly 
immunogenic, as the DD genome has the highest number of potential immunogenic α-gliadin 
peptides [37], while those from the BB genome contribute the least [38,39]. We found that the three 
Figure 4. ce of CD canonical epitopes and variants per wheat species. (a) Abundance
in the DQ2.5-glia-α1 epitope variants, (b) abunda ce in DQ2.5-glia-α1 epitope variant by species,
(c) abundance in DQ2.5-glia-α2 epitope variants, (d) abundance in DQ2.5-glia-α2 epitope variants by
species, (e) abundance in DQ2.5-glia-α3 e it ) ndance in DQ2.5-glia-α2 epitope
variants by species.
Nutrients 2019, 11, 220 8 of 13
Nutrients 2018, 10, x FOR PEER REVIEW  8 of 14 
 
canonical epitopes are present in the DD genome, with a representation ranging from 43% to 65%. In 
hexaploids (BBAADD), all canonical epitopes are also present, but in a smaller proportion (<40%) 
than the DD genome. In contrast, in the AA genome, only DQ2.5-glia-α1 and DQ2.5-glia-α3 are 
present, and the BB genome is not represented by any of the canonical epitopes.  
 
Figure 5. Abundance of epitope variants according to wheat genome type. The epitopes represented 
showed more than 1% of abundance in each gliadin domain. (a) AA genome, (b) BB genome, (c) DD 
genome, (d) BBAA genome, and (e) BBAADD genome. DQ2.5-glia-α1 epitope: green; DQ2.5-glia-α2 
epitope: red; DQ2.5-glia-α3 epitope: blue. 
3.2. Anti-33-mer MoAb Binding Capacity and T-cell Stimulatory of DQ2.5-α-Gliadin-Derived Peptides  
Several of the amino acid variants that we found in the α-gliadin epitope sequences had never 
been described previously, while a number had been described but had never been tested for their 
immunogenic and stimulatory capacities. In order to determine which variants are capable of 
inducing a CD stimulatory response, the variants from DQ2.5-glia-α epitopes were synthesized as 
Figure 5. Abundance of epitope variants according to wheat genome type. The epitopes represented
showed more than 1% of abundance in each gliadin domain. (a) AA genome, (b) BB genome, (c) DD
genome, (d) BBAA genome, and (e) BBAADD genome. DQ2.5-glia-α1 epitope: green; DQ2.5-glia-α2
epitope: red; DQ2.5-glia-α3 epitope: blue.
3.2. Anti-33-mer MoAb Binding Capacity and T-cell Stimulatory of DQ2.5-α-Gliadin-Derived Peptides
Several of the amino acid variants that we found in the α-gliadin epitope sequences had never
been described previously, while a number had been described but had never been tested for their
immunogenic and stimulatory capacities. In order to determine which variants are capable of inducing
a CD stimulatory response, the variants from DQ2.5-glia-α epitopes were synthesized as native and
deaminated peptides and tested for their capacity to bind to anti-33-mer monoclonal antibodies
(moAbs) and to induce T-cell proliferation, respectively (Figure 6). The latter was confirmed with
gamma interferon assays (IFN-γ). The positioning of deamidated glutamine residues is strongly related
to the positioning of proline residues, which is particularly strict in the case of DQ2.5 epitopes (but not
DQ8 epitopes), as DQ2.5 only accepts proline at a certain position in the peptide binding groove [26,40].
The capacity of DQ2.5-glia-α epitopes to trigger proliferation of T cells was tested in deaminated
peptides, deamidation of glutamine (Q) at p6 in DQ2.5-glia-α1 domain, p4 in DQ2.5-glia-α2 domain,
and p4 in DQ2.5-glia-α3 domain.
The DQ2.5-glia-α1 and DQ2.5-glia-α2 epitopes were regarded as major CD epitopes, as they
are recognized by most of CD patients [41]. The anti-33-mer moAbs reacted strongly with the
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canonical DQ2.5-glia-α1 epitope P1{F/Y}2P3Q4P5Q6L7P8Y9. In comparison with the canonical
CD epitope, the variants P1F2L3Q4P5Q6L7P8Y9 (proline (P) to leucine (L) substitution at p3) and
P1F2S3Q4P5Q6L7P8Y9 (P to serine (S) substitution at p3) showed a cross-reactivity (CR) of 37.7% and
55.4%, respectively. With regard to studies of PBMCs in DQ2.5-glia-α1 variants, the single substitution
P to S at p3 maintained similar stimulation capacity to that of the canonical epitope, although it was not
abundant (0.2% to 0.8%) in wheat species. Similarly, the variant with P to L substitution at p3 was very
low in abundance (0.1% to 1.6%) and was found in all the polyploid species except for T. spelta, while
in diploids it was only found in species with the AA genome. However, substitutions of Q to histidine
(H) at p4 and p6, respectively, abolished the stimulatory capacity of this epitope, probably because
it provides a positive charge or via its influence in the deamidation at p6, as previously observed
by Schumann et al. [42]. Moreover, P to L at p8, or two substitutions, also abolished the stimulatory
capacity and showed no affinity for the moAbs (Figure 6a).
As indicated in Figure 6b, the variant P1Q2P3Q4L5P6Y7S8Q9 (P to S substitution at p8)
showed an anti-33-mer binding capacity and PBMC stimulation similar to that of the DQ2.5-glia-α2
canonical CD epitope. This common variant was found in polyploid and diploid species with
AA genome, but was not found in BB and DD genomes. Those peptides with two mismatches,
such as P1Q2P3Q4P5Q6Y7P8Q9 (substitutions L to P at p5 and P to Q at p6), L1Q2P3Q4L5P6Y7S8Q9
(substitutions P to L at p1 and P to S at p8), S1Q2P3Q4L5P6Y7S8Q9 (substitutions P to S at p1 and p8),
and P1Q2P3Q4L5P6H7S8Q9 (substitutions tyrosine (Y) to H at p7, and P to S at p8) showed a CR of
30–40% with respect to the canonical CD epitope and a stimulation index (SI) from 13 to 23 for PBMC
stimulation. In contrast, the replacement of P to L at p3, p6, or p8 showed no reactivity with the
moAbs. Among all of these variants, P1Q2P3Q4L5P6Y7S8Q9 and P1Q2P3Q4P5Q6Y7P8Q9 were the most
frequent variants of the DQ2.5-glia-α2. The modification of P to S at p8 showed high stimulation
with the moAbs and PBMCs, however, two mismatches of L to P at p5 and P to Q at p6 in the same
sequence caused a threefold decrease in the immunogenicity of the DQ2.5-glia-α2 canonical epitope.
This change is abundant in the BBAA genome, especially in the T. turgidum species.
Proliferation assays for PBMC with the canonical DQ2.5-glia-α3 epitope F1R2P3E4Q5P6Y7P8Q9
were tested with E on p4 by tTG2-deamidation of the original Q. Several peptides released an increased
stimulatory effect on T cells, such as the DQ2.5-glia-α3 variant F1L2P3Q4L5P6Y7P8Q9 with two
mismatches. However, other variants for this epitope, with several amino acid substitutions, had no
stimulatory effect on T cells, including P to S substitution at p6, Y to Q at p7, P to Q at p3, and two
substitutions of arginine (R) to P at p2 and Q to H at p9 and R to P at p2 and P to A at p3 (Figure 6c).
The replacement of R to L at p2 and Q to L at p5 in the variant F1L2P3Q4L5P6Y7P8Q9 gave it greater
stimulation capacity, given that this variant was highly abundant for the DQ2.5-glia-α3 epitope, it was
found in all the polyploid species and in the BB diploid genome. However, the non-abundant variant
F1P2P3Q4L5P6Y7P8Q9 with the change of R to P at p2 and Q to L at p5 increased both the binding of
the moAbs and stimulation with T cells. The variant F1R2P3Q4L5P6Y7L8Q9 with one mismatch (P to L
at p8) showed T-cell stimulatory capacity and moAb binding, but was low in abundance (0.6% to 2.5%).
Nevertheless, one of the most abundant variants, F1S2P3Q4Q5P6Y7P8Q9, showed no T-cell stimulatory
capacity and binding of the moAb and was found in the BB diploid genome.
According to the model of HLA-DQ2, the key amino acid residues for DQ2 binding lie at positions
1, 7, and 9, with preferential residues at positions 4 and 6 [43,44]. On the other hand, Elli et al. [45]
found that substitutions at positions 2, 3, 5, and 8 also profoundly affected T-cell stimulation, indicating
that these residues may all interact with the T-cell receptor (TCR). Our findings showed that the change
at position 2 affected T-cell stimulation in the domain DQ2.5-glia-α1, at p8 in the DQ2.5-glia-α2
domain. In addition, the changes at positions 2, 5, and 8 in the DQ2.5-glia-α3 domain profoundly
affected T-cell stimulation. Our results now provide new insights into an alternative approach, since
we have showed that, by introducing specific amino acid substitutions, such as Q to H, at any position,
the toxicity of the three T-cell α-gliadin epitopes could be eliminated. As such, the high level of
variation influencing the immunogenicity of the major CD epitopes may offer possibilities to generate
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new wheat lines with reduced CD-immunogenicity, which may be potentially used as starting points
for the breeding of safe wheats.
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Figure 6. T-cell proliferation and anti-33-mer binding capacity of DQ2.5-glia-α1, DQ2.5-glia-α2,
and DQ2.5-glia-α3 epitope variants and canonical epitope. (a) DQ-2.5-glia-α1 epitope and variants,
(b) DQ-2.5-glia-α2 epitope and variants, and (c) DQ-2.5-glia-α3 epitope and variants. Variants and the
canonical epitope were synthesized as deaminated 9-mer peptides to peripheral blood mononuclear
cell (PBMC) assay. Proliferative responses of T cells were defined as a stimulation index (SI), which
means the specific proliferation of a sample divided by the background proliferation ([PBMC +
peptide]/[PBMC]). Glutamate residues (E) that would be formed by TG2-mediated deamination,
which are important for recognition by T cells, are shown in italics. For the T-cell assay, the responses
are represented relative to the maximum response given by the CD canonical epitope indicated
by ++++. Therefore, - corresponds with 15%; + corresponds with 15–25%; ++ corresponds with
25–50%; +++ corresponds with 50–75%; ++++ corresponds with 75–100%; and +++++ corresponds
with >100%. For the monoclonal antibody (moAb) assay, the amount of antigen detected is represented
relative to the maximum amount (mol/L) detected in a given assay by the CD canonical epitope
indicated by ++++. Therefore, - corresponds with 0%; +/- corresponds with < 5%; + corresponds with
5–10%; ++ corresponds with 10–30%; +++ corresponds to 30–60%; ++++ corresponds to 60–100%; and
+++++corresponds to > 100%. CR; cross-reactivity, was calculated as follows: (IC50 of the antigen
for which the moAb was raised/IC50 of each antigen assayed) × 100. The IC50 is defined as the
concentration of the line that reduces the peak absorbance by 50% in the assay. Each of the letters
represents the amino acid substitution of the variants.
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4. Conclusions
The results presented here about CD DQ2.5 epitopes provide the basis for the introduction
and/or selection of natural amino acid substitutions to eliminate the toxicity of the α-gliadin T-cell
epitopes. Our findings show that the most abundant epitope in the DQ2.5-glia-α1 domain is the CD
canonical epitope. Considering the DQ2.5-glia-α2 domain, the variants P1Q2P3Q4L5P6Y7S8Q9 and
P1Q2P3Q4P5Q6Y7P8Q9 are the most abundant in this domain, while F1P2P3Q4Q5P6Y7P8Q9 is the most
abundant in the DQ2.5-glia-α3 domain. Moreover, the F1P2P3Q4Q5P6Y7P8Q9 variant was also the
most frequent of all the sequences studied. Our data indicate that the changes of P to S and R to P may
be the most representative changes and the natural introduction of Q to H at any position eliminates
the toxicity of the three T-cell epitopes. These results may offer possibilities to generate wheat varieties
with a reduced CD-immunogenicity. Such varieties would help to reduce the presence of immunogenic
CD epitopes in wheat flour and, while not safe for consumption by patients, might help to prevent the
onset of CD in people that carry genetic risk factors. Overall, the more the scientific community knows
about immunogenicity of the gliadins, the closer an alternative therapy besides GFDwill be achieved.
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